Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndromeNature communications, 2019-04, Vol.10 (1), p.1916-1916, Article 1916 [Peer Reviewed Journal]The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-019-09801-x ;PMID: 31015489Full text available |
2 |
Material Type: Article
|
![]() |
The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndromeBMC medicine, 2013-08, Vol.11 (1), p.185-185, Article 185 [Peer Reviewed Journal]COPYRIGHT 2013 BioMed Central Ltd. ;COPYRIGHT 2013 BioMed Central Ltd. ;2013 Rosário et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;Copyright © 2013 Rosário et al.; licensee BioMed Central Ltd. 2013 Rosário et al.; licensee BioMed Central Ltd. ;ISSN: 1741-7015 ;EISSN: 1741-7015 ;DOI: 10.1186/1741-7015-11-185 ;PMID: 23968282Full text available |
3 |
Material Type: Article
|
![]() |
Early recognition of catastrophic antiphospholipid syndrome in patients with antiphospholipid syndrome based on a Chinese cohort studyClinical and experimental rheumatology, 2023-05, Vol.41 (5), p.1017-1023 [Peer Reviewed Journal]ISSN: 0392-856X ;ISSN: 1593-098X ;EISSN: 1593-098X ;DOI: 10.55563/clinexprheumatol/e0voi7 ;PMID: 36062744Full text available |
4 |
Material Type: Article
|
![]() |
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patientsAnnals of the rheumatic diseases, 2015-06, Vol.74 (6), p.1011-1018 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright: 2015 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;(c) BMJ Publishing Group, 2014 info:eu-repo/semantics/openAccess ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2013-204838 ;PMID: 24464962 ;CODEN: ARDIAOFull text available |
5 |
Material Type: Article
|
![]() |
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndromeBlood, 2018-09, Vol.132 (13), p.1365-1371 [Peer Reviewed Journal]2018 American Society of Hematology ;2018 by The American Society of Hematology. ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2018-04-848333 ;PMID: 30002145Full text available |
6 |
Material Type: Article
|
![]() |
Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiologyClinical rheumatology, 2020-09, Vol.39 (9), p.2811-2815 [Peer Reviewed Journal]International League of Associations for Rheumatology (ILAR) 2020 ;International League of Associations for Rheumatology (ILAR) 2020. ;ISSN: 0770-3198 ;EISSN: 1434-9949 ;DOI: 10.1007/s10067-020-05310-1 ;PMID: 32720260Full text available |
7 |
Material Type: Article
|
![]() |
Antiphospholipid syndromeThe Lancet (British edition), 2010-10, Vol.376 (9751), p.1498-1509 [Peer Reviewed Journal]Elsevier Ltd ;2010 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2010 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 30-Nov 5, 2010 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(10)60709-X ;PMID: 20822807 ;CODEN: LANCAOFull text available |
8 |
Material Type: Article
|
![]() |
Clinical course of high‐risk patients diagnosed with antiphospholipid syndromeJournal of thrombosis and haemostasis, 2010-02, Vol.8 (2), p.237-242 [Peer Reviewed Journal]2009 International Society on Thrombosis and Haemostasis ;ISSN: 1538-7933 ;ISSN: 1538-7836 ;EISSN: 1538-7836 ;DOI: 10.1111/j.1538-7836.2009.03674.x ;PMID: 19874470Full text available |
9 |
Material Type: Article
|
![]() |
EULAR recommendations for the management of antiphospholipid syndrome in adultsAnnals of the rheumatic diseases, 2019-10, Vol.78 (10), p.1296-1304 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;ISSN: 1468-2060 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2019-215213 ;PMID: 31092409Full text available |
10 |
Material Type: Article
|
![]() |
Diet, microbiota and autoimmune diseasesLupus, 2014-05, Vol.23 (6), p.518-526 [Peer Reviewed Journal]The Author(s) 2013 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav ;SAGE Publications © May 2014 ;ISSN: 0961-2033 ;EISSN: 1477-0962 ;DOI: 10.1177/0961203313501401 ;PMID: 24763536Full text available |
11 |
Material Type: Article
|
![]() |
Non-criteria manifestations in primary antiphospholipid syndrome: a French multicenter retrospective cohort studyArthritis research & therapy, 2022-01, Vol.24 (1), p.33-33, Article 33 [Peer Reviewed Journal]2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;The Author(s) 2022 ;ISSN: 1478-6362 ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/s13075-022-02726-9 ;PMID: 35078523Full text available |
12 |
Material Type: Article
|
![]() |
Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19Science Translational Medicine, 2020-11, Vol.12 (570) [Peer Reviewed Journal]2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/scitranslmed.abd3876Digital Resources/Online E-Resources |
13 |
Material Type: Article
|
![]() |
Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advancesNature reviews. Rheumatology, 2017-09, Vol.13 (9), p.548-560 [Peer Reviewed Journal]COPYRIGHT 2017 Nature Publishing Group ;COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group Sep 2017 ;ISSN: 1759-4790 ;EISSN: 1759-4804 ;DOI: 10.1038/nrrheum.2017.124 ;PMID: 28769114Full text available |
14 |
Material Type: Article
|
![]() |
Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registryRheumatology (Oxford, England), 2020-06, Vol.59 (6), p.1306-1314 [Peer Reviewed Journal]The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com 2019 ;The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/kez419 ;PMID: 31580459Full text available |
15 |
Material Type: Article
|
![]() |
Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPSBlood, 2020-01, Vol.135 (4), p.239-251 [Peer Reviewed Journal]2020 American Society of Hematology ;2020 by The American Society of Hematology. ;2020 by The American Society of Hematology 2020 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2019003863 ;PMID: 31812994Full text available |
16 |
Material Type: Article
|
![]() |
Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective studyBlood, 2011-10, Vol.118 (17), p.4714-4718 [Peer Reviewed Journal]2011 American Society of Hematology ;2015 INIST-CNRS ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2011-03-340232 ;PMID: 21765019Full text available |
17 |
Material Type: Article
|
![]() |
An advanced understanding of the heterogeneous clinical features of "non-criteria" obstetric antiphospholipid syndrome: Two case reports and a literature reviewFrontiers in immunology, 2023-02, Vol.14, p.1122127-1122127 [Peer Reviewed Journal]Copyright © 2023 Peng, Tan and Xing. ;Copyright © 2023 Peng, Tan and Xing 2023 Peng, Tan and Xing ;ISSN: 1664-3224 ;EISSN: 1664-3224 ;DOI: 10.3389/fimmu.2023.1122127 ;PMID: 36865564Full text available |
18 |
Material Type: Article
|
![]() |
Inhibition of the mTORC Pathway in the Antiphospholipid SyndromeThe New England journal of medicine, 2014-07, Vol.371 (4), p.303-312 [Peer Reviewed Journal]Copyright © 2014 Massachusetts Medical Society. All rights reserved. ;2015 INIST-CNRS ;COPYRIGHT 2014 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1312890 ;PMID: 25054716 ;CODEN: NEJMAGFull text available |
19 |
Material Type: Article
|
![]() |
Anti‐protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndromeJournal of thrombosis and haemostasis, 2014-11, Vol.12 (11), p.1801-1809 [Peer Reviewed Journal]2014 International Society on Thrombosis and Haemostasis ;2014 International Society on Thrombosis and Haemostasis. ;Copyright © 2014 International Society on Thrombosis and Haemostasis ;ISSN: 1538-7933 ;ISSN: 1538-7836 ;EISSN: 1538-7836 ;DOI: 10.1111/jth.12722 ;PMID: 25196808Full text available |
20 |
Material Type: Article
|
![]() |
HYdroxychloroquine to Improve Pregnancy Outcome in Women with AnTIphospholipid Antibodies (HYPATIA) Protocol: A Multinational Randomized Controlled Trial of Hydroxychloroquine versus Placebo in Addition to Standard Treatment in Pregnant Women with Antiphospholipid Syndrome or AntibodiesSeminars in thrombosis and hemostasis, 2017-09, Vol.43 (6), p.562-571 [Peer Reviewed Journal]ISSN: 0094-6176 ;EISSN: 1098-9064 ;DOI: 10.1055/s-0037-1603359Digital Resources/Online E-Resources |